HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring
4.5 (657) · $ 21.99 · In stock
HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient
Foods January-2 2022 - Browse Articles
NuraLogix researchers announce AI models that can predict Blood
Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots
Molecules, Free Full-Text
NuraLogix researchers announce AI models that can predict Blood
Metabolites, Free Full-Text
Somavedic Launches AI-Enabled, Biomarker Analysis App
Smart Labs Archives - Medtech Alert
R: Package Index
Metabolites, Free Full-Text
Labbook 2022
HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring
Frontiers Deep Learning-Based Automatic Assessment of Lung
